Evidence map›Paper›PMID 36962175›Full record

ArticlePLOS global public health2022

Evaluation of kidney function among people living with HIV initiating antiretroviral therapy in Zambia.

Jake M Pry, Michael J Vinikoor, Carolyn Bolton Moore, Monika Roy, Aaloke Mody, Izukanji Sikazwe, Anjali Sharma, Belinda Chihota, Miquel Duran-Frigola, Harriet Daultrey and 5 more

Erratum issuedFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jake M PryCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0001-6312-4420
Michael J VinikoorSchool of Medicine University of Alabama, Birmingham, Alabama, United States of America.ORCID https://orcid.org/0000-0002-3862-7795
Carolyn Bolton MooreCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0001-9103-7746
Monika RoySchool of Medicine, University of California, San Francisco, California, United States of America.
Aaloke ModySchool of Medicine, Washington University, St. Louis, Missouri, United States of America.ORCID https://orcid.org/0000-0003-3787-365X
Izukanji SikazweCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0002-3898-2607
Anjali SharmaCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8189-0732
Belinda ChihotaCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0001-6565-9306
Miquel Duran-FrigolaErsilia Open Source Initiative, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-9906-6936
Harriet DaultreySchool of Medicine, University of California, Davis, California, United States of America.
Jacob MutaleCentre for Infectious Disease Research Zambia (CIDRZ), Lusaka, Zambia.ORCID https://orcid.org/0000-0002-8914-0645
Andrew D KerkhoffSchool of Medicine, University of California, San Francisco, California, United States of America.ORCID https://orcid.org/0000-0002-5023-6658
Elvin H GengSchool of Medicine, Washington University, St. Louis, Missouri, United States of America.
Brad H PollockSchool of Medicine, University of California, Davis, California, United States of America.ORCID https://orcid.org/0000-0003-4415-8638
Jaime H VeraDepartment of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.ORCID https://orcid.org/0000-0002-1165-0573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the response to the HIV epidemic in sub-Saharan Africa continues to mature, a growing number of people living with HIV (PLHIV) are aging and risk for non-communicable diseases increases. Routine laboratory tests of serum creatinine have been conducted to assess HIV treatment (ART) suitability. Here we utilize those measures to assess kidney function impairment among those initiating ART. Identification of non-communicable disease (NCD) risks among those in HIV care creates opportunity to improve public health through care referral and/or NCD/HIV care integration. We estimated glomerular filtration rates (eGFR) using routinely collected serum creatinine measures among a cohort of PLHIV with an HIV care visit at one of 113 Centre for Infectious Disease Research Zambia (CIDRZ) supported sites between January 1, 2011 and December 31, 2017, across seven of the ten provinces in Zambia. We used mixed-effect Poisson regression to assess predictors of eGFR <60ml/min/1.73m2 allowing random effects at the individual and facility level. Additionally, we assessed agreement between four eGFR formulae with unadjusted CKD-EPI as a standard using Scott/Fleiss method across five categories of kidney function. A total of 72,933 observations among 68,534 individuals met the inclusion criteria for analysis. Of the 68,534, the majority were female 41,042 (59.8%), the median age was 34 (interquartile range [IQR]: 28-40), and median CD4 cell count was 292 (IQR: 162-435). The proportion of individuals with an eGFR <60ml/min/1.73m2 was 6.9% (95% CI: 6.7-7.1%) according to the unadjusted CKD-EPI equation. There was variation in agreement across eGFR formulas considered compared to unadjusted CKD-EPI (χ2 p-value <0.001). Estimated GFR less than 60ml/min/1.73m2, per the unadjusted CKD-EPI equation, was significantly associated with age, sex, body mass index, and blood pressure. Using routine serum creatinine measures, we identified a significant proportion of individuals with eGFR indicating moderate or great kidney function impairment among PLHIV initiating ART in Zambia. It is possible that differentiated service delivery models could be developed to address this subset of those in HIV care with increased risk of chronic kidney disease.

Identifiers

PMID36962175
PMCPMC10021838

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read310
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.